ALK: a tyrosine kinase target for cancer therapy.
Holla VR, Elamin YY, Bailey AM, Johnson AM, Litzenburger BC, Khotskaya YB, Sanchez NS, Zeng J, Shufean MA, Shaw KR, Mendelsohn J, Mills GB, Meric-Bernstam F, Simon GR.
Holla VR, et al. Among authors: khotskaya yb.
Cold Spring Harb Mol Case Stud. 2017 Jan;3(1):a001115. doi: 10.1101/mcs.a001115.
Cold Spring Harb Mol Case Stud. 2017.
PMID: 28050598
Free PMC article.
Review.